Trials / Conditions / Stage IIIB Uterine Corpus Cancer AJCC v8

Stage IIIB Uterine Corpus Cancer AJCC v8

7 registered clinical trials studyying Stage IIIB Uterine Corpus Cancer AJCC v8 — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Pa NCT05092373	M.D. Anderson Cancer Center	Phase 1
Recruiting	Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli NCT05269381	Mayo Clinic	Phase 1 / Phase 2
Recruiting	Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors NCT07259304	University of Southern California	—
Recruiting	IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801	M.D. Anderson Cancer Center	Phase 1
Completed	Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gyn NCT04269837	Ohio State University Comprehensive Cancer Center	N/A
Completed	Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913	City of Hope Medical Center	—
Active Not Recruiting	A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Re NCT03008408	M.D. Anderson Cancer Center	Phase 2